Form 4: Third Harmonic Bio Dissolves, CEO Reports Share Cancellation
Insider Transaction Report (Dissolution Related)
Third Harmonic Bio, Inc. has dissolved, leading to the cancellation of shares and derivative securities, with a liquidation distribution of $5.35 per share.
Summary
- Third Harmonic Bio, Inc. (THRD) has undergone dissolution.
- Reporting person Natalie C. Holles, CEO and Director, reported the cancellation of all her beneficially owned common stock, stock options, and restricted stock units.
- A liquidation distribution of $5.35 per share of Common Stock was received by the reporting person.
- 1,218,836 shares of common stock were cancelled.
- 998,854 stock options were cancelled, with the liquidation distribution applied less their exercise price.
- 50,000 restricted stock units were deemed vested and settled, receiving the $5.35 per share liquidation distribution.
Sentiment
Score: 2
Explanation: The dissolution of a company is a highly negative event, signifying the complete failure of its business model or strategy. While a liquidation distribution was made, it represents the end of the investment rather than ongoing value creation.
Positives
- Shareholders received a liquidation distribution of $5.35 per share.
Negatives
- The company, Third Harmonic Bio, Inc., has dissolved.
- All common stock, stock options, and restricted stock units held by the reporting person were cancelled.
Risks
- The ultimate risk of company dissolution has materialized, resulting in the cessation of operations and trading.
Future Outlook
The company has dissolved, indicating no future operational outlook or ongoing business activities.
Management Comments
- Transaction reported is a cancellation of shares of common stock in connection with the dissolution of the Issuer.
- The reporting person received a liquidation distribution of $5.35 per share of Common Stock from Issuer.
- The restricted stock units were deemed vested and settled on the date of the liquidation distribution, and such settled shares received a liquidation distribution of $5.35 per share.
Industry Context
The dissolution of Third Harmonic Bio, Inc. represents a company-specific event, rather than a broad industry trend. It signifies the complete cessation of operations for this particular entity within its sector.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| CEO and Director | Natalie C. Holles | NA | 08/11/2025 | Company dissolution. |
Stakeholder Impact
- Shareholders: Received a final liquidation distribution of $5.35 per share, but their investment in the ongoing company is lost due to dissolution.
- Employees: Likely terminated due to company dissolution.
- Customers/Suppliers: Business relationships ceased due to company dissolution.
Next Steps
- Finalization of the dissolution process for Third Harmonic Bio, Inc.
- Shareholders receiving the liquidation distribution.
Key Dates
| Date | Description |
|---|---|
| 08/11/2025 | Date of earliest transaction related to the dissolution and cancellation of securities. |
| 08/14/2025 | Signature date of the reporting person for the Form 4 filing. |
Recommendation
sellThe company has dissolved, meaning there is no ongoing business or future prospects. The shares are no longer trading, and the only remaining action for shareholders is to receive the liquidation distribution. Any remaining shares should be considered 'sold' as the company no longer exists.
Keywords
Third Harmonic Bio, THRD, Dissolution, Liquidation, SEC Form 4, Share Cancellation, Stock Options, Restricted Stock Units, Natalie Holles
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.